Roivant Sciences (ROIV) Divestments (2023 - 2024)
Roivant Sciences (ROIV) reported Divestments of $185.6 million for Q4 2024, up 290.71% on a YoY basis from $47.5 million in Q1 2024, and up 290.71% quarter-over-quarter from $47.5 million in Q4 2023.
Roivant Sciences (ROIV) Divestments (2023 - 2024) Analysis & Trends
Roivant Sciences has reported Divestments for 2 years, with the latest figure at $185.6 million in Q4 2024.
- For the quarter ending Q4 2024, Divestments rose 290.71% year-over-year to $185.6 million; the trailing twelve-month figure through Dec 2025 stood at $233.1 million (changed N/A YoY), and the FY2025 full-year result was $260.6 million, up 448.6% from the prior year.
- Divestments for Q4 2024 stood at $185.6 million, up from $47.5 million in the prior quarter.
- The five-year high for Divestments was $185.6 million in Q4 2024, with the low at $47.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 185.59 Mn |
| Dec 31, 2023 | 47.50 Mn |